# Leflunomide Treatment for IgG4-RD

> **NCT03715699** · NA · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Autoimmune Disease

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Prednisone and Leflunomide

## Key facts

- **NCT ID:** NCT03715699
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03715699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03715699, "Leflunomide Treatment for IgG4-RD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03715699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*